Synthetic agonists of TLR 9

Details for Australian Patent Application No. 2010208250 (hide)

Owner Idera Pharmaceuticals, Inc.

Inventors Kandimalla, Ekambar; Putta, Mallikarjuna; Wang, Daqing; Yu, Dong; Bhagat, Lakshmi; Agrawal, Sudhir

Agent Freehills

Pub. Number AU-A-2010208250

PCT Pub. Number WO2010/088395

Priority 61/280,065 29.10.09 US; 61/148,527 30.01.09 US

Filing date 28 January 2010

Wipo publication date 5 August 2010

International Classifications

C12N 15/115 (2010.01) Mutation or genetic engineering - Aptamers, i.e. nucleic acids binding a target molecule specifically and with high affinity without hybridising therewith

C12N 15/117 (2010.01) Mutation or genetic engineering - Nucleic acids having immunomodulatory properties, e.g. containing CpG-motifs

Event Publications

4 August 2011 Amendment Made

  The nature of the amendment is as shown in the statement(s) filed 14 Jul 2011

4 August 2011 PCT application entered the National Phase

  PCT publication WO2010/088395 Priority application(s): WO2010/088395

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2010208256-Tape comprising recycled paper

2010208247-Carboxamide compounds and methods for using the same